William Matthews, Constantine Anagnostopoulos, Richard Hawkins, Michael Sember, Andre Marion, Carol Reed, Gregory Sullivan | GenomeWeb

Four weeks after announcing that its president had left, Deltagen said Feb. 13 that its CEO, William Matthews, had resigned.

Matthews, a co-founder of Deltagen, has served as CEO since 1998. The office of board chairman, Constantine Anagnostopoulos, will manage the company until it finds a new CEO, Deltagen said.

The firm has been publicly searching for a new chief since November, but Matthews was co-directing day-to-day operations with Anagnostopoulos and CFO Richard Hawkins.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.